By B. Colby Hamilton | August 23, 2017
Acknowledging the rarity of such a step, U.S. District Chief Judge Colleen McMahon of the Southern District of New York said she was compelled to break with a U.S. magistrate judge's recommendation to allow an expert to testify in a suit over Alzheimer's drugs.
By njlawjournal | New Jersey Law Journal | August 23, 2017
Claims of Favorable Reverse Payment Settlement Agreements Were Sufficient to Constitute Allegation of Anticompetitive Activity
By Stephanie Forshee | August 22, 2017
Simon Property Group Inc., the largest mall operator in the United States, is ending decades-old practices alleged to be anti-competitive at one of its New York outlet shopping malls after reaching a $945,000 settlement with New York Attorney General Eric Schneiderman.
By Charles Toutant | August 21, 2017
The U.S. Court of Appeals for the Third Circuit has overturned the dismissal of two antitrust suits over "reverse settlements" in which patent holders sought to delay the sale of generic versions of blockbuster drugs.
By Elai Katz | August 21, 2017
Antitrust columnist Elai Katz writes: In a thorough opinion evaluating the legality of a health insurance merger under antitrust law, the D.C. Circuit considered whether and when efficiencies may offset competitive concerns. Rejecting arguments that anticipated health care cost reductions should spare Anthem's proposed acquisition of Cigna from an antitrust challenge, a split panel upheld an injunction blocking the proposed merger because it was likely to lessen competition without offsetting benefits.
By Jenna Greene | August 21, 2017
Litigation is rarely nice. But sometimes it's so ugly that you just have to stop and gawk. The antitrust battle between pharmaceutical manufacturing and marketing companies Procaps SA and Patheon Inc. is one of those cases.
By Sue Reisinger | August 18, 2017
It's just the latest instance of federal regulators pointing the finger at CCOs.
By thelegalintelligencer | The Legal Intelligencer | August 18, 2017
Defendant's summary judgment motion on Sherman Act violation denied to the extent plaintiffs presented sufficient evidence that defendant's shift in price increase strategy represented "abrupt" change for industry and was paralleled by sole competitor. Summary judgment denied in part and granted in part.
By SUE REISINGER | August 14, 2017
It's unusual for the DOJ to actively oppose the granting of cert in a case it brought in the past, even if there's a new attorney general in town.
By Zack Needles | August 9, 2017
The U.S. Court of Appeals for the Third Circuit has upheld a Pennsylvania federal judge's dismissal of antitrust claims against GlaxoSmithKline over a patent infringement settlement with generic drugmakers allegedly aimed at delaying market entry of generic versions of the popular antidepressant Wellbutrin XL.
Presented by BigVoodoo
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
Celebrate outstanding achievement in law firms, chambers, in-house legal departments and alternative business structures.
We are seeking an associate to join our Employee Benefits practice. Candidates should have three to six years of employee benefits experienc...
Associate attorney position at NJ Immigration Law firm: Leschak & Associates, LLC, based in Freehold, NJ, is looking for a full time ass...
Seeking a compassionate and experienced estate administration attorney for growing boutique estate planning and elder law practice. Huge eq...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS